Literature DB >> 12716461

Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.

Teiichiro Honda1, Gen Tamura, Takayoshi Waki, Zhe Jin, Kiyoshi Sato, Teiichi Motoyama, Sumio Kawata, Wataru Kimura, Satoshi Nishizuka, Yoshinori Murakami.   

Abstract

The TSLC1 (tumor suppressor in lung cancer-1) gene is a novel tumor suppressor gene on chromosomal region 11q23.2, and is frequently inactivated by concordant promoter hypermethylation and loss of heterozygosity (LOH) in non-small cell lung cancer (NSCLC). Because LOH on 11q has also been observed frequently in other human neoplasms including gastric cancer, we investigated the promoter methylation status of TSLC1 in 10 gastric cancer cell lines and 97 primary gastric cancers, as well as the corresponding non-cancerous gastric tissues, by bisulfite-SSCP analysis followed by direct sequencing. Allelic status of the TSLC1 gene was also investigated in these cell lines and primary gastric cancers. The TSLC1 promoter was methylated in two gastric cancer cell lines, KATO-III and ECC10, and in 15 out of 97 (16%) primary gastric cancers. It was not methylated in non-cancerous gastric tissues, suggesting that this hypermethylation is a cancer-specific alteration. KATO-III and ECC10 cells retained two alleles of TSLC1, both of which showed hypermethylation, associated with complete loss of gene expression. Most of the primary gastric cancers with promoter methylation also retained heterozygosity at the TSLC1 locus on 11q23.2. These data indicate that bi-allelic hypermethylation of the TSLC1 promoter and resulting gene silencing occur in a subset of primary gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12716461      PMCID: PMC5927103          DOI: 10.1111/j.1349-7006.2002.tb01329.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  13 in total

1.  Quantitative DNA methylation analysis by fluorescent polymerase chain reaction single-strand conformation polymorphism using an automated DNA sequencer.

Authors:  H Suzuki; F Itoh; M Toyota; T Kikuchi; H Kakiuchi; Y Hinoda; K Imai
Journal:  Electrophoresis       Date:  2000-03       Impact factor: 3.535

2.  TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.

Authors:  M Kuramochi; H Fukuhara; T Nobukuni; T Kanbe; T Maruyama; H P Ghosh; M Pletcher; M Isomura; M Onizuka; T Kitamura; T Sekiya; R H Reeves; Y Murakami
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

3.  A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2.

Authors:  H Gomyo; Y Arai; A Tanigami; Y Murakami; M Hattori; F Hosoda; K Arai; Y Aikawa; H Tsuda; S Hirohashi; S Asakawa; N Shimizu; E Soeda; Y Sakaki; M Ohki
Journal:  Genomics       Date:  1999-12-01       Impact factor: 5.736

4.  Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.

Authors:  B G Schneider; M L Gulley; P Eagan; J C Bravo; R Mera; J Geradts
Journal:  Hum Pathol       Date:  2000-01       Impact factor: 3.466

Review 5.  Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach.

Authors:  G Tamura
Journal:  Pathol Int       Date:  1996-11       Impact factor: 2.534

6.  Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.

Authors:  K Ohmura; G Tamura; Y Endoh; K Sakata; T Takahashi; T Motoyama
Journal:  Hum Pathol       Date:  2000-09       Impact factor: 3.466

7.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.

Authors:  M Negrini; D Rasio; G M Hampton; S Sabbioni; S Rattan; S L Carter; A L Rosenberg; G F Schwartz; Y Shiloh; W K Cavenee
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

8.  Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.

Authors:  M Davis; A Hitchcock; W D Foulkes; I G Campbell
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

9.  Loss of heterozygosity at 11q22-q23 in breast cancer.

Authors:  S L Carter; M Negrini; R Baffa; D R Gillum; A L Rosenberg; G F Schwartz; C M Croce
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

10.  Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability.

Authors:  K Sakata; G Tamura; Y Endoh; K Ohmura; S Ogata; T Motoyama
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

View more
  21 in total

1.  Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related?

Authors:  Annie On On Chan; Shiu Kum Lam; Benjamin Chun-Yu Wong; Yok-Lam Kwong; Asif Rashid
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach.

Authors:  Mitsuhiko Osaki; Toshiaki Inoue; Shigeyuki Yamaguchi; Aiko Inaba; Naruo Tokuyasu; Kuan-Teh Jeang; Mitsuo Oshimura; Hisao Ito
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

3.  Effect of TSLC1 gene on proliferation, invasion and apoptosis of human hepatocellular carcinoma cell line HepG2.

Authors:  Li Qin; Wentao Zhu; Tao Xu; Youhua Hao; Zhengmao Zhang; Yongjun Tian; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

4.  Clinicopathological analysis in PTCL-NOS with CADM1 expression.

Authors:  Takeharu Kato; Hiroaki Miyoshi; Seiichiro Kobayashi; Noriaki Yoshida; Yoshitaka Imaizumi; Masao Seto; Kaoru Uchimaru; Yasushi Miyazaki; Koichi Ohshima
Journal:  Virchows Arch       Date:  2017-09-22       Impact factor: 4.064

5.  Tslc1 (nectin-like molecule-2) is essential for spermatozoa motility and male fertility.

Authors:  Ezequiel I Surace; Amy Strickland; Rex A Hess; David H Gutmann; Cathy K Naughton
Journal:  J Androl       Date:  2006-07-12

6.  Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer.

Authors:  Motonobu Saito; Akiteru Goto; Noriko Abe; Katsuharu Saito; Daichi Maeda; Tohru Ohtake; Yoshinori Murakami; Seiichi Takenoshita
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

7.  SynCAM, a novel putative tumor suppressor, suppresses growth and invasiveness of glioblastoma.

Authors:  Xiaoju Zhang; Wei Li; Yi Kang; Jianguo Zhang; Huijuan Yuan
Journal:  Mol Biol Rep       Date:  2013-08-02       Impact factor: 2.316

8.  LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.

Authors:  Xiaoyong Qin; Jie Yao; Peiliang Geng; Xiangping Fu; Jinghui Xue; Zhiwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 9.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

10.  The minimal Tumor Suppressor in Lung Cancer-1 promoter is restrained by an inhibitory region.

Authors:  Roderick T Hori
Journal:  Mol Biol Rep       Date:  2009-08-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.